{"transactions":[{"id":1486727,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CFO"}}],"security":"Restricted Stock Units","published_at":"2024-06-07T20:35:10.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":40000,"derivative":{"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-015995","document":"form4-06072024_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924015995/form4-06072024_080605.xml","form_type":"4"}},{"id":1486726,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-07T20:35:10.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested or vests as to 1/48 of the total award on April 15, 2024, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":14.17,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-24-015995","document":"form4-06072024_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924015995/form4-06072024_080605.xml","form_type":"4"}},{"id":1568623,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2024-03-20T00:36:00.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":false,"shares":13100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The award vested or vests as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":39300,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":13100},"source":{"system":"sec-edgar","filing":"0001415889-24-008690","document":"form4-03202024_120350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924008690/form4-03202024_120350.xml","form_type":"4"}},{"id":1568622,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-03-20T00:36:00.000Z","date":"2024-03-19","kind":"sale","planned":false,"acquired":false,"shares":4116,"price":6.0986,"value":25101.8376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.94 to $6.40, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20746,"source":{"system":"sec-edgar","filing":"0001415889-24-008690","document":"form4-03202024_120350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924008690/form4-03202024_120350.xml","form_type":"4"}},{"id":1568621,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-03-20T00:36:00.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":true,"shares":13100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24862,"source":{"system":"sec-edgar","filing":"0001415889-24-008690","document":"form4-03202024_120350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924008690/form4-03202024_120350.xml","form_type":"4"}},{"id":1721670,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-12-05T21:20:14.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":60773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"48,792 restricted stock units will vest on December 1, 2024 and 11,981 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date."}],"balance_after":60773,"derivative":{"expiration_date":"2025-12-01","underlying":"Common Stock","underlying_shares":60773},"source":{"system":"sec-edgar","filing":"0001209191-23-057410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123057410/doc4.xml","form_type":"4"}},{"id":1721669,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-05T21:20:14.000Z","date":"2023-12-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":107400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On December 1, 2023, the Issuer cancelled, pursuant to the Issuer's option exchange program, options to purchase 107,400 shares of Common Stock of the Issuer and in exchange issued to the reporting person 33,561 restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The canceled option vested as to 1/48th of the total award on April 15, 2022 and provided for 1/48th of the total award to vest monthly thereafter, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":20.34,"expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0001209191-23-057410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123057410/doc4.xml","form_type":"4"}},{"id":1721668,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-05T21:20:14.000Z","date":"2023-12-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On December 1, 2023, the Issuer cancelled, pursuant to the Issuer's option exchange program, options to purchase 65,600 shares of Common Stock of the Issuer and in exchange issued to the reporting person 8,463 restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The canceled option vested as to 1/48th of the total award on April 2, 2021 and provided for 1/48th of the total award to vest monthly thereafter, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":60,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":65600},"source":{"system":"sec-edgar","filing":"0001209191-23-057410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123057410/doc4.xml","form_type":"4"}},{"id":1721667,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-05T21:20:14.000Z","date":"2023-12-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 1, 2023, the Issuer cancelled, pursuant to the Issuer's option exchange program, options to purchase 60,000 shares of Common Stock of the Issuer and in exchange issued to the reporting person 18,749 restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The canceled option vested as to 1/48th of the total award on April 25, 2020 and provided for 1/48th of the total award to vest monthly thereafter, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":20.25,"expiration_date":"2030-03-24","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-23-057410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123057410/doc4.xml","form_type":"4"}},{"id":1946961,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-17T20:36:02.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":52400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":52400,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":52400},"source":{"system":"sec-edgar","filing":"0001209191-23-019669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123019669/doc4.xml","form_type":"4"}},{"id":1946960,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-17T20:36:02.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":78600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the total shares on April 15, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":78600,"derivative":{"exercise_price":9.15,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":78600},"source":{"system":"sec-edgar","filing":"0001209191-23-019669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123019669/doc4.xml","form_type":"4"}},{"id":2091087,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-09T22:13:03.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the total shares on January 7, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to reporting\nperson's continued service to the issuer through each vesting date."}],"balance_after":62000,"derivative":{"exercise_price":7.07,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001209191-22-060548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122060548/doc4.xml","form_type":"4"}},{"id":2244684,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-03T21:00:31.000Z","date":"2022-06-02","kind":"exercise","acquired":false,"shares":11160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 1/4th of the total shares on March 15, 2020, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":168837,"derivative":{"exercise_price":4.48,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":11160},"source":{"system":"sec-edgar","filing":"0001209191-22-034170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122034170/doc4.xml","form_type":"4"}},{"id":2244683,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-06-03T21:00:31.000Z","date":"2022-06-02","kind":"exercise","acquired":true,"shares":11160,"price":4.48,"value":49996.8,"ownership":{"direct":true},"balance_after":11762,"source":{"system":"sec-edgar","filing":"0001209191-22-034170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122034170/doc4.xml","form_type":"4"}},{"id":2327432,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-17T21:17:28.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the total shares on April 15, 2022 and then 1/48th of the total shares vest monthly thereafter, subject to reporting\nperson's continued service to the issuer through each vesting date."}],"balance_after":107400,"derivative":{"exercise_price":20.34,"expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0001209191-22-019687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122019687/doc4.xml","form_type":"4"}},{"id":2808801,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-04T22:04:50.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":65600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the total shares on April 2, 2021 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date."}],"balance_after":65600,"derivative":{"exercise_price":60,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":65600},"source":{"system":"sec-edgar","filing":"0001209191-21-017878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121017878/doc4.xml","form_type":"4"}},{"id":2835894,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-24T22:15:59.000Z","date":"2021-02-23","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/4th of the total shares on March 15, 2020, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":179997,"derivative":{"exercise_price":4.48,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-013897","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121013897/doc4.xml","form_type":"4"}},{"id":2835893,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-24T22:15:59.000Z","date":"2021-02-22","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/4th of the total shares on March 15, 2020, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":184997,"derivative":{"exercise_price":4.48,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-013897","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121013897/doc4.xml","form_type":"4"}},{"id":2835892,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-02-24T22:15:59.000Z","date":"2021-02-23","kind":"sale","acquired":false,"shares":5000,"price":58.5983,"value":292991.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":602,"source":{"system":"sec-edgar","filing":"0001209191-21-013897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121013897/doc4.xml","form_type":"4"}},{"id":2835891,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-02-24T22:15:59.000Z","date":"2021-02-23","kind":"exercise","acquired":true,"shares":5000,"price":4.48,"value":22400.0,"ownership":{"direct":true},"balance_after":5602,"source":{"system":"sec-edgar","filing":"0001209191-21-013897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121013897/doc4.xml","form_type":"4"}},{"id":2835890,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-02-24T22:15:59.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":102,"price":60,"value":6120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":602,"source":{"system":"sec-edgar","filing":"0001209191-21-013897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121013897/doc4.xml","form_type":"4"}},{"id":2835889,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-02-24T22:15:59.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":9696,"price":59.2865,"value":574841.904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $59.00 to $59.96 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":704,"source":{"system":"sec-edgar","filing":"0001209191-21-013897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121013897/doc4.xml","form_type":"4"}},{"id":2835888,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-02-24T22:15:59.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":15202,"price":58.6727,"value":891942.3854,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $58.00 to $58.99 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10400,"source":{"system":"sec-edgar","filing":"0001209191-21-013897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121013897/doc4.xml","form_type":"4"}},{"id":2835887,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-02-24T22:15:59.000Z","date":"2021-02-22","kind":"exercise","acquired":true,"shares":25000,"price":4.48,"value":112000.0,"ownership":{"direct":true},"balance_after":25602,"source":{"system":"sec-edgar","filing":"0001209191-21-013897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121013897/doc4.xml","form_type":"4"}},{"id":2992840,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":33268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vested as to 1/4th of the total shares on March 15, 2020, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":209997,"derivative":{"exercise_price":4.48,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":33268},"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992839,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":1732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vested as to 1/4th of the total shares on March 15, 2020, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":243265,"derivative":{"exercise_price":4.48,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":1732},"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992838,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-02","kind":"exercise","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vested as to 1/4th of the total shares on March 15, 2020, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":244997,"derivative":{"exercise_price":4.48,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992837,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":5216,"price":41.9689,"value":218909.7824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $41.81 to $42.19 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":602,"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992836,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":11111,"price":41.4197,"value":460214.2867,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $40.78 to $41.74 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5818,"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992835,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":16941,"price":40.0263,"value":678085.5483,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $39.76 to $40.73 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16929,"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992834,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-04","kind":"exercise","acquired":true,"shares":33268,"price":4.48,"value":149040.64,"ownership":{"direct":true},"balance_after":33870,"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992833,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-03","kind":"sale","acquired":false,"shares":1732,"price":39.8369,"value":68997.5108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $39.805 to $39.90 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":602,"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992832,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-03","kind":"exercise","acquired":true,"shares":1732,"price":4.48,"value":7759.36,"ownership":{"direct":true},"balance_after":2334,"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992831,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":400,"price":38.435,"value":15374.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":602,"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992830,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":14445,"price":37.8615,"value":546909.3675,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $37.43 to $38.38 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1002,"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992829,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":20155,"price":36.7873,"value":741448.0315,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $36.43 to $37.36 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15447,"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":2992828,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-11-04T22:31:40.000Z","date":"2020-11-02","kind":"exercise","acquired":true,"shares":35000,"price":4.48,"value":156800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 602 shares of  Common Stock acquired under the issuer's employee stock purchase plan on June 30, 2020."}],"balance_after":35602,"source":{"system":"sec-edgar","filing":"0001209191-20-056953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/doc4.xml","form_type":"4"}},{"id":3194379,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-26T22:07:16.000Z","date":"2020-03-25","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the total shares on April 25, 2020 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":20.25,"expiration_date":"2030-03-24","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-021321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120021321/doc4.xml","form_type":"4"}},{"id":4005034,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-08T21:38:54.000Z","date":"2018-03-06","kind":"grant","acquired":true,"shares":125670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2018."}],"balance_after":125670,"derivative":{"exercise_price":8.6,"expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":125670},"source":{"system":"sec-edgar","filing":"0000899243-18-006817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924318006817/doc4.xml","form_type":"4"}},{"id":4005033,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-08T21:38:54.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":3153,"price":3.995,"value":12596.235,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"Represents the voluntary reporting of 3,153 shares of common stock acquired under the Issuer's ESPP in December 2017."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the voluntary reporting of 3,153 shares of common stock acquired under the Issuer's ESPP in December 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 3, 2017."}],"balance_after":8563,"source":{"system":"sec-edgar","filing":"0000899243-18-006817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924318006817/doc4.xml","form_type":"4"}},{"id":4005032,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-08T21:38:54.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":2077,"price":3.9525,"value":8209.3425,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the voluntary reporting of 2,077 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in June 2017."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the voluntary reporting of 2,077 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in June 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2017."}],"balance_after":5410,"source":{"system":"sec-edgar","filing":"0000899243-18-006817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924318006817/doc4.xml","form_type":"4"}},{"id":4396869,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-07T22:45:29.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":220980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2017."}],"balance_after":220980,"derivative":{"exercise_price":5.1,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":220980},"source":{"system":"sec-edgar","filing":"0000899243-17-006711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924317006711/doc4.xml","form_type":"4"}},{"id":4435527,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":90153,"kind":"person","name":"Tulipano Stephen J","position":1,"cik":"0001360548","reported_name":"Tulipano Stephen J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-21T21:30:25.000Z","date":"2017-02-17","kind":"purchase","acquired":true,"shares":3333,"price":4.5,"value":14998.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017."}],"balance_after":3333,"source":{"system":"sec-edgar","filing":"0000899243-17-004750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924317004750/doc4.xml","form_type":"4"}}]}